John Cooke, MD, PhD
Publications
- Therapeutic transdifferentiation: a novel approach for vascular disease. Circ Res. 2013; (5): 748-50
- Activation of innate immunity is required for efficient nuclear reprogramming. Cell. 2012; (3): 547-58
- Endothelial cells derived from nuclear reprogramming. Circ Res. 2012; (10): 1363-75
- Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat Med. 2012; (12): 1841-6
- DDAH says NO to ADMA. Arterioscler Thromb Vasc Biol. 2011; (7): 1462-4
- Dietary nitrate, nitric oxide, and restenosis. J Clin Invest. 2011; (4): 1258-60
- Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2011; (11): e72-9
- MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus. Circulation. 2011; (3): 236-8
- Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol. 2010; (5): 984-91
- Role of nitric oxide signaling in endothelial differentiation of embryonic stem cells. Stem Cells Dev. 2010; (10): 1617-26
- Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. J Cell Biochem. 2009; (2): 433-46
- Embryonic stem cell-derived endothelial cells for treatment of hindlimb ischemia. J Vis Exp. 2009; (23)
- Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol. 2008; (4): 692-7
- A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol. 2007; (1): 106-12
- Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. Circulation. 2005; (11): 1549-56
- Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation. 2005; (11): 1431-8
- Asymmetrical dimethylarginine: the Uber marker? Circulation. 2004; (15): 1813-8
- Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation. 2003; (24): 3042-7
- Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell. 2003; (3): 191-6
- A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest. 2002; (4): 527-36
- Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 2002; (8): 987-92
- Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001; (7): 833-9
- Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg. 2013; (3): 728-33
- FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats. PLoS One. 2013; (4): e60653
- Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity. Am J Transl Res. 2013; (1): 21-35
- Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells. Stem Cells. 2013; (1): 92-103
- Spatial patterning of endothelium modulates cell morphology, adhesiveness and transcriptional signature. Biomaterials. 2013; (12): 2928-37
- The modulation of endothelial cell morphology, function, and survival using anisotropic nanofibrillar collagen scaffolds. Biomaterials. 2013; (16): 4038-47
- The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis. J Pathol. 2013; (2): 242-9
- Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. Am J Cardiol. 2013; (6): 851-6
- Development of pluripotent stem cells for vascular therapy. Vascul Pharmacol. 2012 May-Jun; (5-6): 288-96
- A validated biomarker panel to identify peripheral artery disease. Vasc Med. 2012; (6): 386-93
- Aligned nanofibrillar collagen regulates endothelial organization and migration. Regen Med. 2012; (5): 649-61
- Bioluminescence imaging of stem cell-based therapeutics for vascular regeneration. Theranostics. 2012; (4): 346-54
- Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening. J Biomol Screen. 2012; (5): 651-61
- Endovascular correction of cerebrovenous anomalies in multiple sclerosis: a retrospective review of an uncontrolled case series. Vasc Med. 2012; (3): 131-7
- Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. Atherosclerosis. 2012; (1): 138-47
- Genetics of peripheral artery disease. Circulation. 2012; (25): 3220-8
- Imaging vascular nicotine receptors: a new window onto vascular disease. JACC Cardiovasc Imaging. 2012; (5): 537-9
- In Memoriam of John T. Shepherd, MD, DSc. Circulation. 2012; (2): 393-4
- Lymphangiogenesis: a potential new therapy for lymphedema? Circulation. 2012; (7): 853-5
- Nicotine and pathological angiogenesis. Life Sci. 2012; (21-22): 1058-64
- Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal. 2012; (4): 363-73
- PPARδ activation protects endothelial function in diabetic mice. Diabetes. 2012; (12): 3285-93
- Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation. 2011; (20): 2236-43
- Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance. Cardiovasc Diabetol. 2011: 68
- Low lifetime recreational activity is a risk factor for peripheral arterial disease. J Vasc Surg. 2011; (2): 427-32, 432.e1-4
- Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes. Diabet Med. 2011; (9): 1088-95
- Solubility partner IF2 Domain I enables high yield synthesis of transducible transcription factors in Escherichia coli. Protein Expr Purif. 2011; (1): 145-51
- The role of nicotine in the pathogenesis of atherosclerosis. Atherosclerosis. 2011; (2): 281-3
- Two decades of progress in vascular medicine. Am J Med. 2011; (9): 791-2
- A matrix micropatterning platform for cell localization and stem cell fate determination. Acta Biomater. 2010; (12): 4614-21
- Assessing endothelial vasodilator function with the Endo-PAT 2000. J Vis Exp. 2010; (44)
- Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. Vasc Med. 2010; (4): 267-74
- Biomarkers of peripheral arterial disease. J Am Coll Cardiol. 2010; (19): 2017-23
- Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease? Vasc Med. 2010; (5): 375-85
- Chronic exposure to nicotine impairs cholinergic angiogenesis. Vasc Med. 2010; (1): 47-54
- DDAH: a target for vascular therapy? Vasc Med. 2010; (3): 235-8
- Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res. 2010; (3): 551-8
- Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. Arthritis Rheum. 2010; (6): 1718-22
- Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization. Vasc Med. 2010; (6): 443-50
- Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation. 2010; (5): 517-26
- The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol. 2010; (11): 2089-98
- Topical mecamylamine for diabetic macular edema. Am J Ophthalmol. 2010; (5): 839-51.e1
- Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol. 2009; (1): 83-99
- Cell-free production of transducible transcription factors for nuclear reprogramming. Biotechnol Bioeng. 2009; (6): 1047-58
- Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk? J Psychiatr Res. 2009; (16): 1246-52
- Extensive characterization of the human DDAH1 transgenic mice. Pharmacol Res. 2009; (6): 494-502
- Hypercholesterolemia impairs exercise capacity in mice. Vasc Med. 2009; (3): 249-57
- Murine model of hindlimb ischemia. J Vis Exp. 2009; (23)
- nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS One. 2009; (9): e7040
- Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus. Transplantation. 2008; (6): 827-33
- Endothelial nicotinic acetylcholine receptors and angiogenesis. Trends Cardiovasc Med. 2008; (7): 247-53
- Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation. Stroke. 2008; (1): 180-4
- Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants. Kidney Blood Press Res. 2008; (4): 259-67
- A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization. J Urol. 2007; (6): 2342-6
- Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci. 2007; (24-25): 2347-51
- Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation. 2007; (12): 1396-403
- Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation. 2007; (6): 700-5
- Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation. 2007; (11 Suppl): I46-54
- Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury. J Am Coll Cardiol. 2007; (10): 1099-105
- Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J Clin Microbiol. 2007; (6): 1804-10
- Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol. 2007; (10): 2068-78
- L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation. 2007; (2): 188-95
- NOx and ADMA changes with focal ischemia, amelioration with the chaperonin GroEL. Neurosci Lett. 2007; (2): 201-4
- Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007; (4): 581-9
- SVMB Presidential address: Vascular medicine: past, present and future. Vasc Med. 2007; (3): 215-8
- Should we measure asymmetric dimethylarginine in patients with coronary artery disease? Clin Chem. 2007; (2): 161-3
- Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk. Psychosom Med. 2006 Jul-Aug; (4): 538-46
- A pilot study of ranolazine in patients with intermittent claudication. Int Angiol. 2006; (4): 361-9
- ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke. 2006; (8): 2024-9
- Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation. 2006; (3): 398-405
- Endothelial progenitor cells participate in nicotine-mediated angiogenesis. J Am Coll Cardiol. 2006; (12): 2553-60
- Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med. 2006; (3): 155-63
- Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. FASEB J. 2006; (14): 2657-9
- Response to Letter by Tsuda. Stroke. 2006
- SVMB presidential address. The time has come for vascular medicine. Vasc Med. 2006; (3): 177-80
- Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. Nephrol Dial Transplant. 2006; (9): 2446-51
- T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation. 2006; (15): 1608-15
- ADMA regulates angiogenesis: genetic and metabolic evidence. Vasc Med. 2005; (1): 7-14
- ADMA: its role in vascular disease. Vasc Med. 2005: S11-7
- Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med. 2005: S35-43
- Mechanisms of Raynaud's disease. Vasc Med. 2005; (4): 293-307
- Vascular compliance versus flow-mediated vasodilation: correlation with cardiovascular risk factors. Vasc Med. 2005; (4): 275-83
- Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia. Circulation. 2004; (16): 2424-9
- Capillary electrophoretic and micellar electrokinetic separations of asymmetric dimethyl-L-arginine and structurally related amino acids: quantitation in human plasma. J Sep Sci. 2004; (17-18): 1483-90
- Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation. 2004; (4): 500-5
- Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia. Circulation. 2004; (10): 1314-9
- Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis. Gene Ther. 2004; (3): 302-9
- Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc Med. 2004; (1): 26-30
- Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med. 2004; (1): 33-40
- The pivotal role of nitric oxide for vascular health. Can J Cardiol. 2004: 7B-15B
- A novel mechanism for pulmonary arterial hypertension? Circulation. 2003; (12): 1420-1
- Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway. Arterioscler Thromb Vasc Biol. 2003; (4): 567-75
- Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation. 2003; (8): 933-8
- Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A. 2003; (3): 768-70
- Flow-responsive remodeling after angioplasty is enhanced by high cholesterol diet. Prevention with pyrrolidine dithiocarbamate. Atherosclerosis. 2003; (2): 333-41
- NO and angiogenesis. Atheroscler Suppl. 2003; (4): 53-60
- NOS inhibition accelerates atherogenesis: reversal by exercise. Am J Physiol Heart Circ Physiol. 2003; (2): H535-40
- Nicotine promotes arteriogenesis. J Am Coll Cardiol. 2003; (3): 489-96
- Effect of local delivery of L-arginine on in-stent restenosis in humans. Am J Cardiol. 2002; (4): 363-7
- Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol. 2002; (11): 1817-23
- Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Metabolism. 2002; (7): 843-6
- Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol. 2002; (1): 97-104
- Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002; (11): 1420-6
- Short polymers of arginine rapidly translocate into vascular cells: effects on nitric oxide synthesis. Circ J. 2002; (12): 1155-60
- Statins have biphasic effects on angiogenesis. Circulation. 2002; (6): 739-45
- Atherogenesis and the arginine hypothesis. Curr Atheroscler Rep. 2001; (3): 252-9
- Cholesterol-induced upregulation of angiotensin II and its effects on monocyte-endothelial interaction and superoxide production. Vasc Med. 2001; (3): 133-8
- Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001; (21): 2569-75
- L-arginine enhances aerobic exercise capacity in association with augmented nitric oxide production. J Appl Physiol. 2001; (3): 933-8
- Maintaining the endothelium: preventive strategies for vessel integrity. Prev Cardiol. 2001; (1): 28-37
- Nicotine is an agent of angiogenesis. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001; (7): 833-9
- Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol. 2001; (10): 1201-3
- eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res. 2001; (9): 793-8
- An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol. 2000; (7): 2287-95
- Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation. 2000; (12): 1414-9
- Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol. 2000; (4): 1040-6
- Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med. 2000; (4): 296-300
- Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma. Vasc Med. 2000; (3): 147-58
- Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000; (9): 2032-7
- Maintaining the endothelium: preventive strategies for vessel integrity. Prev Cardiol. 2000; (4): 172-177
- Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin). Circulation. 2000; (19): 2322-4
- Phytoestrogens and cardiovascular health. J Am Coll Cardiol. 2000; (6): 1403-10
- Rapid and efficient vascular transport of arginine polymers inhibits myointimal hyperplasia. Circulation. 2000; (21): 2629-35
- The endothelium: a new target for therapy. Vasc Med. 2000; (1): 49-53
- Fibroblast growth factor as therapy for critical limb ischemia: a case report. Vasc Med. 1999; (2): 89-91
- Gene transfer of nitric oxide synthase: effects on endothelial biology. J Am Coll Cardiol. 1999; (4): 1201-7
- Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. Am J Physiol. 1999; (4 Pt 2): H1346-54
- L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study. Vasc Med. 1999; (1): 27-32
- Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation. 1999; (17): 1830-5
- Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers. Circulation. 1999; (9): 940-3
- Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 1999; (24): 3092-5
- Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation. 1999; (9): 1236-41
- [Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis]. J Cardiol. 1999; (2): 105-6
- Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998; (18): 1842-7
- Cardiovascular effects of L-arginine. Curr Opin Nephrol Hypertens. 1998; (1): 63-70
- Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction. J Cardiovasc Pharmacol. 1998: S48-53
- Images in vascular medicine. Phlegmasia coerulea dolens--venous gangrene. Vasc Med. 1998; (1): 29-31
- Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioscler Thromb Vasc Biol. 1998; (6): 947-53
- Is atherosclerosis an arginine deficiency disease? J Investig Med. 1998; (8): 377-80
- Limb blood flow during exercise is dependent on nitric oxide. Circulation. 1998; (4): 369-74
- Nutriceuticals for cardiovascular health. Am J Cardiol. 1998; (10A): 43S-46S
- Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Intern Med. 1998: 253-77
- Thromboangiitis obliterans. An update on Buerger's disease. West J Med. 1998; (4): 255-60
- Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM. Diabetes Care. 1997; (9): 1462-5
- Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine. Arterioscler Thromb Vasc Biol. 1997; (12): 3557-64
- Anti-CD43 inhibits monocyte-endothelial adhesion in inflammation and atherogenesis. Blood. 1997; (9): 3587-94
- Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol. 1997; (3): 479-85
- Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation. 1997; (7): 1863-9
- Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 1997; (3): 934-40
- Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med. 1997: 489-509
- Novel vascular molecule involved in monocyte adhesion to aortic endothelium in models of atherogenesis. J Exp Med. 1997; (12): 2069-77
- Role of digital artery adrenoceptors in Raynaud's disease. Vasc Med. 1997; (1): 1-7
- The pathophysiology of peripheral arterial disease: rational targets for drug intervention. Vasc Med. 1997; (3): 227-30
- Therapeutic interventions in endothelial dysfunction: endothelium as a target organ. Clin Cardiol. 1997; (11 Suppl 2): II-45-51
- A novel therapy for lymphedema complicated by lymphorrhea. Vasc Med. 1996; (4): 247-50
- Acute myocardial infarction in a young woman with systemic lupus erythematosus. Vasc Med. 1996; (1): 19-23
- Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol. 1996; (6): 1573-9
- Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol. 1996; (7): 1652-60
- Felodipine inhibits intimal lesion formation in the hypercholesterolemic rabbit: differential effects on endothelial and monocyte determinants of atherogenesis. Vasc Med. 1996; (3): 173-9
- Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation. 1996; (7): 1682-9
- Hypertension-enhanced monocyte adhesion in experimental atherosclerosis. J Vasc Surg. 1996; (4): 596-605
- Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 1996; (4): 720-9
- Regression or progression. Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol. 1996; (1): 44-50
- Role of nitric oxide in progression and regression of atherosclerosis. West J Med. 1996; (5): 419-24
- Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits. J Cardiovasc Pharmacol. 1995; (5): 710-6
- Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. Circulation. 1995; (12): 3513-9
- Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest. 1995; (3): 1363-9
- Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995; (4): 1137-41
- Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A. 1995; (10): 4502-6
- Medical therapy of peripheral arterial occlusive disease. Surg Clin North Am. 1995; (4): 569-79
- The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA. 1995; (24): 1919-25
- Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol. 1994; (2): 452-8
- Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. Circulation. 1994; (4): 1615-23
- Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994; (5): 2176-82
- L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb. 1994; (10): 1529-33
- The vasculopathy of aging. J Gerontol. 1994; (5): B191-6
- Vascular injury augments adrenergic neurotransmission. Circulation. 1994; (2): 777-84
- Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling. Circulation. 1993; (1): 193-7
- Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation. 1993; (3): 705-19
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992; (3): 1168-72
- The role of endothelial dysfunction in restenosis. Rev Port Cardiol. 1992; (10): 889-92
- Endothelial dysfunction in hypercholesterolemia is corrected by L-arginine. Basic Res Cardiol. 1991: 173-81
- Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991; (5): 1663-71
Help
Trial Administration